nandrolone decanoate has been researched along with Behavior Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Busardò, FP; Fineschi, V; Frati, P; Napoletano, S; Pinchi, E; Sanzo, MD; Zaami, S | 1 |
| Ahmed, MA; El-Awdan, SA | 1 |
1 review(s) available for nandrolone decanoate and Behavior Disorders
| Article | Year |
|---|---|
The impact of nandrolone decanoate on the central nervous system.
Topics: Anabolic Agents; Animals; Central Nervous System; Central Nervous System Diseases; Humans; Mental Disorders; Nandrolone; Nandrolone Decanoate | 2015 |
1 other study(ies) available for nandrolone decanoate and Behavior Disorders
| Article | Year |
|---|---|
Lipoic acid and pentoxifylline mitigate nandrolone decanoate-induced neurobehavioral perturbations in rats via re-balance of brain neurotransmitters, up-regulation of Nrf2/HO-1 pathway, and down-regulation of TNFR1 expression.
Topics: Acetylcholine; Animals; Antioxidants; Brain; Down-Regulation; Heme Oxygenase-1; Male; Mental Disorders; Nandrolone; Nandrolone Decanoate; Neuroprotective Agents; Neurotransmitter Agents; NF-E2-Related Factor 2; Oxidative Stress; Pentoxifylline; Rats; Rats, Wistar; Receptors, Tumor Necrosis Factor, Type I; Signal Transduction; Thioctic Acid; Up-Regulation | 2015 |